CENTOGENE supports the development of new therapies for Duchenne Muscular Dystrophy by offering actionable real-world insights along the end-to-end pharmaceutical development workflow.
Gaucher disease (GD) is among the most prevalent, recessively inherited, lysosomal storage disorders (LSDs).
Niemann-Pick disease type C (NPC) is a slow-progressing disorder in which the primary hallmark is accumulation of lipids in lysosomes.
Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting approximately 2% of the population over 60 years of age.
Our global network of customer support and experts guiding you every step of the way.
Send us a messageRegional Support
